| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1000107598 |
| P356 | DOI | 10.1186/1479-5876-10-135 |
| P932 | PMC publication ID | 3441208 |
| P698 | PubMed publication ID | 22747650 |
| P5875 | ResearchGate publication ID | 228099363 |
| P2093 | author name string | Yaojun Zhang | |
| Li Xu | |||
| Minshan Chen | |||
| Hengjun Gao | |||
| Furong Liu | |||
| Zhenwei Peng | |||
| P2860 | cites work | Global cancer statistics | Q22241238 |
| HMGB1 and HMGB2 cell-specifically down-regulate the p53- and p73-dependent sequence-specific transactivation from the human Bax gene promoter | Q24292041 | ||
| Release of chromatin protein HMGB1 by necrotic cells triggers inflammation | Q28131815 | ||
| High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal | Q28242907 | ||
| Management of hepatocellular carcinoma | Q29616230 | ||
| High-mobility group box 1 and cancer | Q33638306 | ||
| Co-expression of nuclear and cytoplasmic HMGB1 is inversely associated with infiltration of CD45RO+ T cells and prognosis in patients with stage IIIB colon cancer | Q33693936 | ||
| Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release and resultant inflammation. | Q34004850 | ||
| Prognostic value of HMGB1 overexpression in resectable gastric adenocarcinomas | Q34019875 | ||
| Inhibitor of NF-kappa B kinases alpha and beta are both essential for high mobility group box 1-mediated chemotaxis [corrected] | Q34043446 | ||
| Knockdown of HMGB1 in tumor cells attenuates their ability to induce regulatory T cells and uncovers naturally acquired CD8 T cell-dependent antitumor immunity | Q35059053 | ||
| Focus on hepatocellular carcinoma. | Q35721877 | ||
| Updated treatment approach to hepatocellular carcinoma. | Q36097844 | ||
| Molecular interactions between dying tumor cells and the innate immune system determine the efficacy of conventional anticancer therapies | Q37179972 | ||
| High mobility group box-1 induces migration of vascular smooth muscle cells via TLR4-dependent PI3K/Akt pathway activation | Q38334036 | ||
| Overexpression of high-mobility group box 1 correlates with tumor progression and poor prognosis in human colorectal carcinoma | Q38419290 | ||
| Knockdown of RAGE expression inhibits colorectal cancer cell invasion and suppresses angiogenesis in vitro and in vivo | Q39468495 | ||
| Immunological relatedness of high mobility group chromosomal proteins from calf thymus | Q39475541 | ||
| Hypoxia-increased RAGE and P2X7R expression regulates tumor cell invasion through phosphorylation of Erk1/2 and Akt and nuclear translocation of NF-{kappa}B. | Q39530433 | ||
| Elevated expression of HMGB1 in squamous-cell carcinoma of the head and neck and its clinical significance | Q39665543 | ||
| The DNA-bending protein HMGB1 is a cellular cofactor of Sleeping Beauty transposition | Q39749628 | ||
| Intracellular high mobility group B1 protein (HMGB1) represses HIV-1 LTR-directed transcription in a promoter- and cell-specific manner | Q40630436 | ||
| HMGB1 activates nuclear factor-κB signaling by RAGE and increases the production of TNF-α in human umbilical vein endothelial cells | Q43158876 | ||
| HMGB1 enhances the proinflammatory activity of lipopolysaccharide by promoting the phosphorylation of MAPK p38 through receptor for advanced glycation end products | Q43248408 | ||
| Increased expression of high mobility group box 1 (HMGB1) is associated with progression and poor prognosis in human nasopharyngeal carcinoma. | Q45966478 | ||
| High-mobility group box 1 is associated with clinicopathologic features in patients with hepatocellular carcinoma. | Q54346270 | ||
| NK/iDC interaction results in IL-18 secretion by DCs at the synaptic cleft followed by NK cell activation and release of the DC maturation factor HMGB1 | Q57374973 | ||
| Serum high mobility group box chromosomal protein 1 is associated with clinicopathologic features in patients with hepatocellular carcinoma | Q80759305 | ||
| P921 | main subject | hepatocellular carcinoma | Q1148337 |
| hepatectomy | Q1514021 | ||
| P304 | page(s) | 135 | |
| P577 | publication date | 2012-07-02 | |
| P1433 | published in | Journal of Translational Medicine | Q15716664 |
| P1476 | title | High expression of high mobility group box 1 (hmgb1) predicts poor prognosis for hepatocellular carcinoma after curative hepatectomy | |
| P478 | volume | 10 |
| Q41071962 | Antiseptic effect of vicenin-2 and scolymoside from Cyclopia subternata (honeybush) in response to HMGB1 as a late sepsis mediator in vitro and in vivo |
| Q35025037 | Association of Upregulated HMGB1 and c-IAP2 Proteins With Hepatocellular Carcinoma Development and Progression |
| Q85914546 | Clinical value of serum HMGB1 in diagnosis and prognosis of laryngeal squamous cell carcinoma |
| Q53450710 | Correlation of High Mobility Group Box-1 Protein (HMGB1) with Clinicopathological Parameters in Primary Retinoblastoma. |
| Q37446034 | Emerging role of high-mobility group box 1 (HMGB1) in liver diseases |
| Q38388188 | Evaluation of a novel tissue stabilization gel to facilitate clinical sampling for translational research in surgical trials |
| Q36502721 | Expression of high mobility group box 1 protein predicts a poorer prognosis for patients with osteosarcoma |
| Q34622835 | HMGB1 in health and disease |
| Q38203471 | HMGB1 in hormone-related cancer: a potential therapeutic target |
| Q38890114 | HMGB1 overexpression as a prognostic factor for survival in cancer: a meta-analysis and systematic review |
| Q36212999 | HMGB1-mediated autophagy modulates sensitivity of colorectal cancer cells to oxaliplatin via MEK/ERK signaling pathway |
| Q40917751 | High Serum Levels of the Interleukin-33 Receptor Soluble ST2 as a Negative Prognostic Factor in Hepatocellular Carcinoma |
| Q47135468 | High mobility group box 1 promotes sorafenib resistance in HepG2 cells and in vivo |
| Q36190325 | High-mobility group protein box1 expression correlates with peritumoral macrophage infiltration and unfavorable prognosis in patients with hepatocellular carcinoma and cirrhosis |
| Q90677056 | Immunogenic Cell Death Driven by Radiation-Impact on the Tumor Microenvironment |
| Q26853543 | Management of hepatocellular carcinoma: Predictive value of immunohistochemical markers for postoperative survival |
| Q64054072 | MicroRNA-665 inhibits the oncogenicity of retinoblastoma by directly targeting high-mobility group box 1 and inactivating the Wnt/β-catenin pathway |
| Q52562715 | Overexpression of high mobility group box 1 contributes to progressive clinicopathological features and poor prognosis of human bladder urothelial carcinoma. |
| Q26864508 | Potential role of High mobility group box 1 in hepatocellular carcinoma |
| Q52145169 | Primary glioblastoma multiforme tumors and recurrence : Comparative analysis of the danger signals HMGB1, HSP70, and calreticulin. |
| Q35999764 | Prognostic Significance of Tag SNP rs1045411 in HMGB1 of the Aggressive Gastric Cancer in a Chinese Population |
| Q26795466 | Prognostic and Predictive Value of DAMPs and DAMP-Associated Processes in Cancer |
| Q48188138 | Serum HMGB1 concentrations at 4 weeks is a useful predictor of extreme poor prognosis for advanced hepatocellular carcinoma treated with sorafenib and hepatic arterial infusion chemotherapy. |
| Q47736069 | Strong renal expression of heat shock protein 70, high mobility group box 1, inducible nitric oxide synthase, and nitrotyrosine in mice model of severe malaria |
| Q37170567 | The association of HMGB1 expression with clinicopathological significance and prognosis in Asian patients with colorectal carcinoma: a meta-analysis and literature review |
| Q34428389 | The association of HMGB1 expression with clinicopathological significance and prognosis in hepatocellular carcinoma: a meta-analysis and literature review |
| Q35875277 | The microRNA-325 inhibits hepatocellular carcinoma progression by targeting high mobility group box 1. |
| Q37685447 | The role of high mobility group box 1 (HMGB1) in colorectal cancer |
| Q92648977 | microRNA-548b suppresses aggressive phenotypes of hepatocellular carcinoma by directly targeting high-mobility group box 1 mRNA |
Search more.